---
figid: PMC9052532__13045_2022_1273_Fig3_HTML
figtitle: 'Gut microbiota influence immunotherapy responses: mechanisms and therapeutic
  strategies'
organisms:
- Escherichia coli
- Salmonella enterica subsp. enterica serovar Typhimurium
- Listeria monocytogenes
- Clostridioides difficile
- Lactiplantibacillus plantarum
- Lactococcus lactis
- Bacteroides fragilis
- Limosilactobacillus reuteri
- Lactobacillus acidophilus
- Bifidobacterium longum
- Akkermansia muciniphila
- Salmonella enterica subsp. enterica serovar Typhi
- Enterococcus faecium
- Clostridium butyricum
- Burkholderia cepacia
- Bifidobacterium breve
- Bifidobacterium animalis subsp. lactis
- Escherichia coli Nissle 1917
- Leuconostoc mesenteroides
- Lactobacillus johnsonii
- Roseburia intestinalis
- Clostridium scindens
- Enterococcus hirae
- Bifidobacterium pseudolongum
- Collinsella aerofaciens
- Enterococcus gallinarum
- Faecalibaculum rodentium
- Bacteroides caccae
- Streptococcus australis
- Anacardium occidentale
- Saccharomyces boulardii nom. inval.
- Halocarpus biformis
- gut metagenome
- human gut metagenome
- Homo sapiens
- Mus musculus
- Gallus gallus
- Bacteriophage sp.
pmcid: PMC9052532
filename: 13045_2022_1273_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9052532/figure/Fig3/
number: F3
caption: Potential mechanisms by which the gut microbial metabolite inosine facilitates
  the efficacy of ICI. Inosine, purine metabolite of gut microbiota A. muciniphila
  and B. pseudolongum, combined with in ICI therapy exert synergistic antitumor effects.
  A Inosine increases the immunogenicity of tumor cells. Inosine can improve the ability
  of tumor cells to present tumor antigens so that cytotoxic immune cells can easily
  recognize and kill tumor cells. B Inosine promotes immune cell activation. Inosine
  could enhance ICI efficacy by acting on A2AR on T lymphocytes. It stimulates the
  phosphorylation of cAMP response element-binding protein (pCREB) through the inosine-A2AR-cAMP-PKA
  signaling pathway, which can upregulate IL12Rβ2 and IFNγ transcription and promote
  Th1-cell differentiation and accumulation in the TME. C Inosine provides an alternative
  carbon source for CD8+ T cells. Inosine can be used as an alternative carbon source
  for CD8+ T cells when glucose is limited and relieves the restrictions on CD8+ T
  cells energy metabolism in tumor cells
papertitle: 'Gut microbiota influence immunotherapy responses: mechanisms and therapeutic
  strategies.'
reftext: Yuting Lu, et al. J Hematol Oncol. 2022;15:47.
year: '2022'
doi: 10.1186/s13045-022-01273-9
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BioMed Central
keywords: Cancer immunotherapy | Immune checkpoint inhibitors | Gut microbiota | Microbiota-derived
  metabolites | Therapeutic strategies
automl_pathway: 0.8834043
figid_alias: PMC9052532__F3
figtype: Figure
organisms_ner:
- Gallus gallus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9052532__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9052532__13045_2022_1273_Fig3_HTML.html
  '@type': Dataset
  description: Potential mechanisms by which the gut microbial metabolite inosine
    facilitates the efficacy of ICI. Inosine, purine metabolite of gut microbiota
    A. muciniphila and B. pseudolongum, combined with in ICI therapy exert synergistic
    antitumor effects. A Inosine increases the immunogenicity of tumor cells. Inosine
    can improve the ability of tumor cells to present tumor antigens so that cytotoxic
    immune cells can easily recognize and kill tumor cells. B Inosine promotes immune
    cell activation. Inosine could enhance ICI efficacy by acting on A2AR on T lymphocytes.
    It stimulates the phosphorylation of cAMP response element-binding protein (pCREB)
    through the inosine-A2AR-cAMP-PKA signaling pathway, which can upregulate IL12Rβ2
    and IFNγ transcription and promote Th1-cell differentiation and accumulation in
    the TME. C Inosine provides an alternative carbon source for CD8+ T cells. Inosine
    can be used as an alternative carbon source for CD8+ T cells when glucose is limited
    and relieves the restrictions on CD8+ T cells energy metabolism in tumor cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD8A
  - TUBA1A
  - AR
  - PNP
  - IL12RB2
  - IFNG
  - IFNA3
  - TH
  - EN
  - EPR
  - TME
  - Trav6-3
  - Pdcd1
  - Cd274
  - Tuba1c
  - Ar
  - Pnp
  - Il12rb2
  - Ifng
  - Hand1
  - Nelfcd
  - Th
  - Nt5e
  - Tme
  - CD8B
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - TUBA1C
  - IL12A
  - IL12B
  - PPY
  - IFNA1
  - NELFCD
  - GBP1P1
  - NT5E
---
